| Steroid biosynthesis |
2.51 |
0.00e+0 |
19/20 (95%) |
MSMO1;DHCR7;CYP51A1;...
|
| Complement and coagulation cascades |
2.14 |
0.00e+0 |
76/85 (89.41%) |
CD55;VWF;C1S;...
|
| Ferroptosis |
2.13 |
0.00e+0 |
36/41 (87.8%) |
SLC7A11;HMOX1;SLC3A2;...
|
| Protein processing in endoplasmic reticulum |
2.11 |
0.00e+0 |
127/171 (74.27%) |
HERPUD1;DDIT3;ATF4;...
|
| Lysosome |
2.06 |
0.00e+0 |
115/128 (89.84%) |
NPC1;PSAP;TPP1;...
|
| PPAR signaling pathway |
2.03 |
0.00e+0 |
66/74 (89.19%) |
SCD;HMGCS1;PCK2;...
|
| Cholesterol metabolism |
1.98 |
0.00e+0 |
44/50 (88%) |
LDLR;NPC1;CYP27A1;...
|
| Terpenoid backbone biosynthesis |
1.93 |
4.38e-3 |
18/22 (81.82%) |
HMGCS1;HMGCR;FDPS;...
|
| Other glycan degradation |
1.86 |
6.48e-3 |
13/18 (72.22%) |
NEU1;AGA;HEXA;...
|
| Metabolism of xenobiotics by cytochrome P450 |
1.86 |
5.84e-3 |
49/77 (63.64%) |
CYP1B1;AKR1C1;GSTA1;...
|
| Glycerolipid metabolism |
1.84 |
8.49e-3 |
44/61 (72.13%) |
ALDH2;PLPP3;AKR1A1;...
|
| Mineral absorption |
1.81 |
1.26e-2 |
48/60 (80%) |
HMOX1;ATP2B1;CYBRD1;...
|
| Phagosome |
1.80 |
1.26e-2 |
118/152 (77.63%) |
HLA-B;SFTPA2;TUBA1A;...
|
| Fluid shear stress and atherosclerosis |
1.79 |
1.42e-2 |
123/139 (88.49%) |
HMOX1;VEGFA;ARHGEF2;...
|
| Biosynthesis of unsaturated fatty acids |
1.77 |
1.40e-2 |
21/27 (77.78%) |
SCD;FADS2;ELOVL5;...
|
| Sphingolipid metabolism |
1.77 |
1.60e-2 |
32/49 (65.31%) |
PLPP3;PSAP;NEU1;...
|
| Steroid hormone biosynthesis |
1.72 |
2.68e-2 |
43/61 (70.49%) |
CYP1B1;AKR1C2;AKR1C1;...
|
| Coronavirus disease |
1.71 |
2.53e-2 |
215/232 (92.67%) |
RPS4Y1;IRF9;MMP1;...
|
| Various types of N-glycan biosynthesis |
1.71 |
2.76e-2 |
26/39 (66.67%) |
MAN2A1;HEXA;HEXB;...
|
| Glycosaminoglycan degradation |
1.70 |
2.74e-2 |
19/19 (100%) |
HEXA;GUSB;HEXB;...
|
| Amino sugar and nucleotide sugar metabolism |
1.69 |
2.72e-2 |
38/48 (79.17%) |
GFPT1;GNPDA1;UGDH;...
|
| Insulin resistance |
1.67 |
3.93e-2 |
96/108 (88.89%) |
PCK2;TRIB3;IRS2;...
|
| RNA polymerase |
-1.68 |
1.69e-2 |
23/31 (74.19%) |
POLR3F;POLR1C;POLR2E;...
|
| Oxidative phosphorylation |
-1.69 |
1.61e-2 |
93/133 (69.92%) |
COX11;SDHC;ATP6V1B2;...
|
| Base excision repair |
-1.76 |
5.52e-3 |
29/33 (87.88%) |
PARP2;APEX2;SMUG1;...
|
| mRNA surveillance pathway |
-1.76 |
5.87e-3 |
71/98 (72.45%) |
NXF1;PPP2R5C;RNGTT;...
|
| RNA degradation |
-1.78 |
4.69e-3 |
53/79 (67.09%) |
C1D;DCPS;LSM4;...
|
| p53 signaling pathway |
-1.79 |
5.03e-3 |
63/73 (86.3%) |
CCND2;BID;CCNG1;...
|
| Huntington disease |
-1.81 |
3.01e-3 |
233/306 (76.14%) |
PSMB2;CASP3;PIK3R4;...
|
| Ribosome biogenesis in eukaryotes |
-1.82 |
2.61e-3 |
52/108 (48.15%) |
IMP4;TCOF1;NHP2;...
|
| Mismatch repair |
-1.91 |
7.11e-4 |
22/23 (95.65%) |
POLD3;RPA1;POLD1;...
|
| Pyrimidine metabolism |
-1.93 |
0.00e+0 |
40/56 (71.43%) |
CTPS2;RRM1;DTYMK;...
|
| RNA transport |
-1.98 |
0.00e+0 |
128/186 (68.82%) |
FUS;EIF4A1;RAN;...
|
| Oocyte meiosis |
-1.99 |
0.00e+0 |
90/129 (69.77%) |
PPP2R1A;PPP1CA;ADCY6;...
|
| Homologous recombination |
-2.02 |
0.00e+0 |
35/41 (85.37%) |
BABAM1;NBN;RAD50;...
|
| Proteasome |
-2.04 |
0.00e+0 |
44/46 (95.65%) |
SEM1;PSMB9;PSME1;...
|
| Fanconi anemia pathway |
-2.05 |
0.00e+0 |
36/54 (66.67%) |
FAAP100;RPA2;TOP3A;...
|
| Spliceosome |
-2.17 |
0.00e+0 |
101/150 (67.33%) |
PRPF18;SF3A2;DHX15;...
|
| Progesterone-mediated oocyte maturation |
-2.25 |
0.00e+0 |
75/100 (75%) |
PIK3R1;KRAS;MAPK10;...
|
| DNA replication |
-2.38 |
0.00e+0 |
34/36 (94.44%) |
RFC2;RPA3;POLE;...
|
| Cell cycle |
-2.59 |
0.00e+0 |
110/124 (88.71%) |
CDK6;CDKN2D;CDC23;...
|
